Literature DB >> 29667729

HLA-DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with gastric cancer.

Shen-Kang Zhou1, Lei-Lei Yang1, Rui Chen1, Yong Lu1, Yong-Hua Zheng2.   

Abstract

BACKGROUND: Gastric cancer (GC) is a disease associated with a higher incidence and mortality, and some host genetic polymorphisms have been reported as potential factors contributing to the development of GC. In view of this, the study was conducted to investigate the effects of HLA-DQB1 gene polymorphisms and perioperative blood transfusion on prognosis of patients with gastric cancer (GC).
METHODS: A total of 142 patients with GC (case group) and 150 healthy controls (control group) were enrolled. Relationship between HLA-DQB1 gene polymorphisms, perioperative blood transfusion, and clinical pathological parameters of patients with GC after operation was analyzed. Kaplan-Meier curve was applied for analyzing survival rate of patients with GC, and Cox multivariate regression analysis for prognostic factors of patients with GC.
RESULTS: The frequency of HLA-DQB1*03 gene was increased in patients with GC. Patients with GC with HLA-DQB1*03 genotype had higher number of tumor size >6 cm, deeper depth of infiltration, higher LNM rate, and later stage of disease. Patients with HLA-DQB1*03 genotype had lower survival rate compared with other genotypes. Anemia before operation, depth of infiltration in T3 stage and T4 stage, LNM in N1 stage and N2 stage, and HLA-DQB1*03 genotype were regarded as independent risk factors for patients with GC.
CONCLUSION: These results demonstrate that HLA-DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with GC, which could provide a reference for the treatment of GC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990HLA-DQB1zzm321990; gastric cancer; gene polymorphism; perioperative blood transfusion; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29667729      PMCID: PMC6817122          DOI: 10.1002/jcla.22443

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  39 in total

1.  T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Authors:  Dennis X Beringer; Fleur S Kleijwegt; Florian Wiede; Arno R van der Slik; Khai Lee Loh; Jan Petersen; Nadine L Dudek; Gaby Duinkerken; Sandra Laban; Antoinette Joosten; Julian P Vivian; Zhenjun Chen; Adam P Uldrich; Dale I Godfrey; James McCluskey; David A Price; Kristen J Radford; Anthony W Purcell; Tatjana Nikolic; Hugh H Reid; Tony Tiganis; Bart O Roep; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  HLA-DQB1 locus and gastric cancer in Helicobacter pylori infection.

Authors:  Yoshinori Watanabe; Nobuo Aoyama; Toshiyuki Sakai; Daisuke Shirasaka; Shuji Maekawa; Kohei Kuroda; Casmir Wambura; Takao Tamura; Yoshisuke Nose; Masato Kasuga
Journal:  J Gastroenterol Hepatol       Date:  2006-02       Impact factor: 4.029

4.  HLA-DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with gastric cancer.

Authors:  Shen-Kang Zhou; Lei-Lei Yang; Rui Chen; Yong Lu; Yong-Hua Zheng
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

5.  Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus.

Authors:  Natalia Castaño-Rodríguez; Lina-Marcela Diaz-Gallo; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmun Rev       Date:  2008-01-07       Impact factor: 9.754

6.  Effect of perioperative blood transfusion on prostate cancer recurrence.

Authors:  Beneranda S Ford; Satish Sharma; Hamed Rezaishiraz; Robert S Huben; James L Mohler
Journal:  Urol Oncol       Date:  2007-11-07       Impact factor: 3.498

Review 7.  Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery.

Authors:  Karen M Devon; Robin S McLeod
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

8.  Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.

Authors:  Yuan Dang; Fenghua Lan; Xiaojuan Ouyang; Kai Wang; Youdong Lin; Yinghao Yu; Lie Wang; Yu Wang; Qiaojia Huang
Journal:  World J Surg Oncol       Date:  2015-10-15       Impact factor: 2.754

Review 9.  Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.

Authors:  Yoon Young Choi; Sung Hoon Noh; Jae-Ho Cheong
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

10.  Differences in the levels of gastric cancer risk factors between Nanjing and Minqing counties, China.

Authors:  Xiang-Quan Xie; Kui-Cheng Zheng; Bing-Shan Wu; Tie-Hui Chen; Shan-Rong Lai; Zai-Sheng Lin; Kazuo Aoki
Journal:  J Prev Med Public Health       Date:  2014-09-12
View more
  2 in total

1.  HLA-DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with gastric cancer.

Authors:  Shen-Kang Zhou; Lei-Lei Yang; Rui Chen; Yong Lu; Yong-Hua Zheng
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

2.  Development of an Immune-Related Gene Signature for Prognosis in Melanoma.

Authors:  Jia-An Zhang; Xu-Yue Zhou; Dan Huang; Chao Luan; Heng Gu; Mei Ju; Kun Chen
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.